Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.27 (
AMPK
)
6,299
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
Ras-related GTP-binding protein
Cdc42 has been implicated in a diversity of biological functions including the regulation of intracellular trafficking and endocytosis. While screening for Cdc42 targets that influence these activities, we identified the protein-tyrosine kinase
ACK2
(for activated Cdc42-associated kinase 2) as a new binding partner for clathrin.
ACK2
binds clathrin via a domain that is conserved among a number of other clathrin-binding proteins including the arrestins and AP-2. Overexpression of
ACK2
in NIH3T3 cells results in an inhibition of transferrin receptor endocytosis because of a competition between
ACK2
and AP-2 for clathrin. Activated Cdc42 weakens the interaction between
ACK2
and clathrin and thus reverses the
ACK2
-mediated inhibition of endocytosis. Overexpression of
ACK2
increases the amount of clathrin present in fractions enriched in clathrin-coated vesicles. Taken together, our data suggest that
ACK2
may represent a novel clathrin-assembly protein and participate in the regulation of receptor-mediated endocytosis.
...
PMID:The Cdc42 target ACK2 directly interacts with clathrin and influences clathrin assembly. 1127 77